Altered Mitochondrial Dynamics in Motor Neuron Disease: An Emerging Perspective

Area of Science:

• Neuroscience
• Cell Biology
• Genetics

Background:

• Mitochondria are crucial for cellular function and survival.
• Mitochondrial dysfunction is implicated in aging and age-associated motor neuron diseases (MNDs), including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
• Amyloidogenic proteins like fused in sarcoma (FUS) and TAR DNA binding protein (TDP)-43 are linked to mitochondrial dysfunction in MNDs.

Purpose of the Study:

• To review recent advances in understanding mitochondrial dysfunction in various MND subgroups.
• To discuss the mechanistic role of mitochondrial dysfunction in MNDs and identify potential therapeutic targets.
• To explore the implications of DNA ligase 3 (LIG3) defects in mitochondrial DNA transactions within the context of FUS-associated ALS.

Main Methods:

• Review of existing literature on mitochondrial dysfunction in MNDs.
• Analysis of findings from animal models and patient studies.
• Discussion of recent research on DNA ligase 3 (LIG3) and its role in FUS-associated ALS.

Main Results:

• MNDs exhibit changes in mitochondrial structure, replication, DNA stability, and membrane potential.
• Mitochondrial abnormalities precede clinical and pathological onset in MND rodent models, suggesting a causal role.
• Defects in DNA ligase 3 (LIG3) are implicated in FUS-associated ALS, raising questions about its role in mitochondrial DNA metabolism.

Conclusions:

• Mitochondrial dysfunction is a significant factor in diverse MNDs.
• Further investigation into the mechanistic role of mitochondrial dysfunction is critical for developing therapeutic strategies.
• Understanding the interplay between MND-associated factors, DNA repair mechanisms, and mitochondrial health is essential for future research.